Intravesical apaziquone administration following...

Details Intravesical apaziquone administration following... Intravesical apaziquone administration following...

A - Human Necessities

61

K

A61K 9/00 (2006.01) A61K 31/404 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2680481

Bladder cancer treatments include the intravesical administration of apaziquone immediately (e.g. within about 6 hours) following transurethral resection.

L'invention concerne des traitements du cancer de la vessie comprenant l'administration intravésicale d'apaziquone immédiatement (par exemple, en moins d'environ 6 heures) après résection transuréthrale.

Affiliated with

Also associated with

Rating

Intravesical apaziquone administration following... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intravesical apaziquone administration following..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravesical apaziquone administration following... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1638588